A patient received dexamethasone 10 mg about 21 hours ago, is on a total of 55 units of NPH insulin, has an insulin sensitivity factor of 1 unit per 15 mg/dL requiring an additional 27 units, and is receiving continuous tube feeding with 269 g of carbohydrate. What should the morning and evening NPH insulin doses be?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 8, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

NPH Insulin Dosing for Dexamethasone-Induced Hyperglycemia on Continuous Tube Feeding

Given the patient's current insulin requirements (55 units baseline + 27 units correction = 82 total units) and dexamethasone-induced hyperglycemia pattern, increase the AM NPH dose to approximately 55 units and the PM NPH dose to approximately 27 units, distributing the total daily dose as 2/3 in the morning and 1/3 in the early evening.

Rationale and Dosing Algorithm

Dexamethasone Effect on Insulin Requirements

The patient received dexamethasone 10 mg 21 hours ago, which creates a characteristic hyperglycemic pattern peaking in the afternoon and evening 1, 2. Current guidelines recommend NPH insulin twice daily with a total dose of 0.3 units/kg per day, giving 2/3 of the total daily dose in the morning and the remaining 1/3 in the early evening 1.

The patient's demonstrated need for 82 total units (baseline 55 + correction 27) indicates their actual insulin requirement under dexamethasone effect. This correction requirement suggests the current regimen is inadequate.

Continuous Tube Feeding Considerations

For continuous enteral nutrition with 269 g carbohydrate, guidelines recommend:

  • 1 unit of insulin per 10-15 g of carbohydrate for the nutritional component 2
  • NPH insulin every 8-12 hours is a reasonable option for continuous feeds 2
  • The basal-nutritional split should favor nutritional coverage

Calculating nutritional needs: 269 g ÷ 12 g/unit = approximately 22-27 units for carbohydrate coverage alone.

Specific Dosing Recommendation

Morning (AM) NPH: 55 units

  • Covers the 2/3 proportion for dexamethasone-induced afternoon/evening hyperglycemia peak
  • Provides basal coverage plus anticipates the steroid effect

Evening (PM) NPH: 27 units

  • Covers the remaining 1/3 proportion
  • Maintains overnight glycemic control
  • Addresses continuous feeding needs

Total Daily Dose: 82 units (matching current demonstrated requirement)

Critical Management Points

Monitoring and Adjustment

  • Check blood glucose every 4-6 hours initially 2
  • Adjust doses frequently based on response 2
  • Continue correctional insulin every 4-6 hours with rapid-acting or every 6 hours with regular insulin 2

Dexamethasone Discontinuation Warning

Insulin requirements can decline rapidly after dexamethasone is stopped 1. When dexamethasone is discontinued:

  • Reduce NPH doses by 30-50% immediately
  • Monitor for hypoglycemia closely
  • Be prepared to start 10% dextrose at 50 mL/h if tube feeding is interrupted 1

Common Pitfalls to Avoid

  1. Underestimating steroid effect: The 2/3 AM dosing is essential because dexamethasone causes peak hyperglycemia in afternoon/evening, not morning 1, 2
  2. Inadequate nutritional insulin: Patients achieving normoglycemia on steroids require higher percentage of nutritional insulin (58% of TDD) versus correctional insulin (7% of TDD) 3
  3. Failure to adjust at discontinuation: 25% of patients experience hypoglycemia when dexamethasone stops 4

If Tube Feeding is Interrupted

  • Immediately start 10% dextrose infusion at 50 mL/h 1
  • Reduce NPH doses by 50% temporarily
  • Resume full doses when feeding restarts

This approach balances the dexamethasone-induced insulin resistance pattern (afternoon/evening peak) with continuous nutritional needs, using the patient's demonstrated requirement of 82 units as the foundation 1, 2.

Related Questions

A patient receiving dexamethasone 20 mg at 8 am for two days, currently on insulin glargine (Lantus) 22 units with a carbohydrate‑to‑insulin ratio of 1 unit per 7 g carbohydrate and an insulin sensitivity factor of 1 unit per 25 mg/dL, needs a steroid‑induced insulin regimen with fixed meal bolus doses. What regimen should be used?
For a 113‑kg (BMI 36) patient with an A1c of 8.0 % and hemoglobin 8.2 g/dL who received dexamethasone 20 mg 24 hours ago and has blood glucose readings of 387, 339, and 301 mg/dL on a high correction scale, what should the insulin glargine (Lantus) dose and carbohydrate‑to‑insulin ratio be for the day after the dexamethasone dose?
Should a patient receiving dexamethasone who has an elevated capillary blood glucose be given a rescue insulin dose?
Two days after stopping dexamethasone, by how much should the insulin-to-carbohydrate ratio be decreased?
In a patient with steroid‑induced hyperglycemia, hemoglobin A1c 8.0%, hemoglobin 8.2 g/dL, who received dexamethasone 20 mg 24 hours ago, weighs 113 kg (BMI 36), what carbohydrate‑to‑insulin ratio should be used the day after dexamethasone and should basal insulin glargine (Lantus) be started?
What clinical features differentiate renal colic from other causes of abdominal colic?
What are the current guidelines for monitoring patients with established cirrhosis?
Should lisinopril be started in a patient with acute kidney injury?
What oral antibiotic(s) are appropriate for treating methicillin‑susceptible Staphylococcus aureus (MSSA) infection in an adult with normal renal and hepatic function?
What is the appropriate treatment for a patient with localized limited cellulitis of the ankle who has no known drug allergies and normal renal and hepatic function?
What is the mechanism behind nausea and vomiting in renal colic?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.